Clinical Trials Directory

Trials / Completed

CompletedNCT05121519

Does Eliminating Coffee Avoid Fibrillation?

A Randomized Controlled Trial to Assess Abstinence of Coffee Compared to Continued Consumption on Recurrent Atrial Fibrillation Following Cardioversion

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Given both the increasing population impact of atrial fibrillation (AF) and the widespread consumption of coffee in society, determining an associated benefit or risk of coffee consumption on AF is of great clinical relevance. This study will evaluate the effect of randomly assigning participants undergoing cardioversion to coffee abstinence or coffee continuation over a 6 month period. This study will provide the first, randomized evaluation of coffee on AF outcomes and will provide important information on whether or not coffee has any effect on AF recurrence.

Detailed description

The purpose of this study is to assess how abstinence of coffee compared to continued consumption affects recurrent atrial fibrillation (AF) following cardioversion. As one of the most consumed beverages in the world, whether coffee has any effect on health outcomes is of considerable interest to physicians, scientists, and individual consumers. While significant data exist on the potential impact of coffee on many cardiometabolic parameters, there is conflicting data on any role of coffee on AF. Most studies so far have been observational in nature, limiting how much insight there is on the role of coffee on AF. This study proposes to directly compare AF outcomes for patients with AF that abstain from coffee versus those that continue coffee consumption. A total of 200 AF patients undergoing cardioversion will be enrolled in this study (100 per arm), and followed for up to 6 months post cardioversion. Differences in AF recurrence and symptoms will be compared between the two groups.

Conditions

Interventions

TypeNameDescription
OTHERConsume coffeeDrink coffee regularly (recommend at least 1 cup of caffeinated coffee or one shot of espresso per day)
OTHERAvoid coffeeAbstain from coffee and other caffeinated products

Timeline

Start date
2021-10-20
Primary completion
2025-06-05
Completion
2025-10-20
First posted
2021-11-16
Last updated
2025-11-26

Locations

3 sites across 3 countries: United States, Australia, Canada

Source: ClinicalTrials.gov record NCT05121519. Inclusion in this directory is not an endorsement.